ArticleScientific reports2024

An analysis of adjuvant chemoradiotherapy versus chemotherapy on the survival rates for patients with stage IB-III uterine serous carcinoma.

Shuqing Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.